meningococcal

Meningococcal meningitis is a bacterial form of meningitis, a serious infection of the thin lining that surrounds the brain and spinal cord.

Meningococcal meningitis is a bacterial form of meningitis, a serious infection of the meninges that affects the brain membrane.

meningococcal meningitis is an infection of the meninges by the bacteria . it is the most common presentation of meningococcal infection.

Meningococcal infection is a serious illness. Suspects should be treated immediately with suitable antibiotics.

Meningococcal disease is endemic in Delhi and sporadic cases of meningococcal meningitis have been occurring in Delhi in previous years.

Meningococcal Disease. Meningococcal disease (bacterial meningitis) is a bacterial infection in the lining of the brain or spinal cord.

Effectiveness of Antibiotics Given before Admission in Reducing Mortality from Meningococcal Disease: Systematic Review .

There is a seasonal risk of meningococcal disease in parts of West Africa, primarily during the dry season from December through June.

Meningococcal disease is potentially fatal and should be viewed as a medical emergency.

abstract: Objective To develop an UV method for determination of phosphorus in group A meningococcal polysaccharide vaccine.

Meningococcal disease is potentially fatal and should always be viewed as a medical emergency.

The close living conditions in dormitories may place these students at a higher risk for meningococcal disease.

Laboratory capacity for the collection and detection of meningococcal disease and management of cases has been strengthened.

This article reports about a young boy with fulminant meningococcal septicemia.

The highest burden of meningococcal disease occurs in sub-Saharan Africa, which is known as the "meningitis belt" .

A Newsletter (CD Alert) focusing on meningococcal disease is being made available to physicians.

Since 1999, meningococcal conjugate vaccines against group C have been available and widely used.

The Department of Health is concerned about the report of outbreaks of meningococcal meningitis in Eastern China.

Meningococcal disease was first described in 1805 when an outbreak swept through Geneva, Switzerland.

From December 2010, a new meningococcal A conjugate vaccine is being introduced nationwide in Burkina Faso, Mali and Niger.

A purplish red rash may appear with meningococcal meningitis.

The clinical picture of fever and haemorrhagic exanthema should always arouse suspicion of serious disease such as meningococcal infection.

Meningococcal infection is caused by the bacteria Neisseria meningitidis.

High coverage of the target age group of 1-29 years is expected to eliminate meningococcal A from this region of Africa.

The vaccine is designed to provide ten years of low-cost protection against meningococcal A.

From 1-31 January 2006, 136 suspected cases and 15 deaths of meningococcal disease have been reported in six states of Sudan.

WHO is committed to eliminating meningococcal disease as a public health problem.

Since 29 March 2005, 111 cases of meningococcal disease have been reported in Delhi till 10 am on 6 May 2005.

Preparation and Stability Study of Group A Meningococcal Polysaccharide Conjugate Vaccine

Study on epidemiology of a suspicious meningococcal meningitis case by molecular biology

Content of polysaccharide; Meningococcal polysaccharide vaccine;

in temperate regions , the number of cases of meningococcal meningitis increases in winter and spring

Immunogenicity of group A meningococcal polysaccharide conjugate

Studies on Safety and Immunogenicity of Group A Meningococcal Polysaccharide Conjugate Vaccine

Epidemic Analysis on Meningococcal Meningitis Prevalence Status and Control Effect in Guangdong Province in 2005

Meningococcal Polysaccharide Vaccine Group A

there have been media reports about fatal meningococcal meningitis outbreaks in some provinces of china

Preparation of Meningococcal Group A Conjugate Vaccine

Past outbreaks of meningococcal meningitis in SEA Region-a brief overview

Meningococcal disease in the African Meningitis Belt, epidemic season 2006